1. Schaber SD, Gergiorgis DI, Ramachandran R, Evans JMB, Barton PI, Trout BL. Economic analysis of integrated continuous and batch pharmaceutical manufacturing: a case study. Ind Eng Chem. 2011;50:10083–92.
https://doi.org/10.1021/ie2006752
.
2. Department of Health and Human Services. Pharmaceutical CGMPs for the 21st century—a risk based approach. United States Food and Drug Administration: Silver Spring, Maryland. 2004.
https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/Manufacturing/QuestionsandAnswersonCurrentGoodManufacturingPracticescGMPforDrugs/UCM176374.pdf
. Accessed 18 Aug 2016.
3. Department of Health and Human Services. Advancement of Emerging Technology Applications to Modernize the Pharmaceutical Manufacturing Base Guidance for Industry. United States Food and Drug Administration: Silver Spring, Maryland. 2015.
https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM478821.pdf
. Accessed 18 Aug 2016.
4. Myerson AS, Krumme M, Nasr M, Thomas H, Braatz RD. Control systems engineering in continuous pharmaceutical manufacturing. May 20–21, 2014 continuous manufacturing symposium. J Pharm Sci. 2015;104:832–9.
https://doi.org/10.1002/jps.24311
.
5. Muteki K, Swaminathan V, Sekulic SS, Reid GL. Feed-forward process control strategy for pharmaceutical tablet manufacture using latent variable modeling and optimization technologies. IFAC Proceedings Volumes. 2012;45(15):51–6.
https://doi.org/10.3182/20120710-4-SG-2026.00076
.